Northcape Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Northcape Wealth Management's PFE Position: Q1 2026 in Review
Northcape Wealth Management increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $122K and bringing the position to 27,430 shares worth $770K. The position accounts for 0.21% of the portfolio, ranked #84.
Northcape Wealth Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.15M in Q1 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Northcape Wealth Management held 27,430 shares of Pfizer worth $770K as of Q1 2026.
- Northcape Wealth Management bought 4,600 Pfizer shares in Q1 2026, an estimated $122K.
- Pfizer made up 0.21% of Northcape Wealth Management's portfolio in Q1 2026, its #84 holding.
- Northcape Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Northcape Wealth Management's Pfizer position peaked at $2.15M in Q1 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.